Two Sigma Advisers’s Colgate-Palmolive CL Stock Holding History

Two Sigma Advisers’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-5,000	Closed	-$341K	–	2367
2014 Q2	$341K	Sell	5,000 -53,000	-91%	-$3.55M	﹤0.01%	1927
2014 Q1	$3.76M	Buy	58,000 +34,000	+142%	+$2.14M	0.03%	517
2013 Q4	$1.56M	Buy	24,000 +1,000	+4%	+$64K	0.02%	885
2013 Q3	$1.36M	Buy	+23,000	New	+$1.36M	0.02%	805

Other funds holding CL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Two Sigma Advisers's CL Position: Q1 2026 in Review

Two Sigma Advisers sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 604,400 shares — an estimated $47.8M sold.

Two Sigma Advisers first reported a position in CL in Q2 2013 and held it in 47 quarters. The position peaked at $284M in Q3 2018. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

Two Sigma Advisers reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
Two Sigma Advisers sold 604,400 Colgate-Palmolive shares in Q1 2026, an estimated $47.8M.
Two Sigma Advisers first reported a position in Colgate-Palmolive in Q2 2013 and held it in 47 quarters.
Two Sigma Advisers's Colgate-Palmolive position peaked at $284M in Q3 2018.
1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.